Webinar: Evidence in Chinese patent enforcement: Key differences with the US

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Webinar: Evidence in Chinese patent enforcement: Key differences with the US

Sponsored by

purplevine-ip.png
MIP article page@4x.jpg

Join Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)

Register here to join Purplevine IP’s webinar: Evidence in Chinese patent enforcement: Key differences with the US.

China has become one of the most litigious countries for patent enforcement. Foreign patentees may therefore face challenges when collecting evidence in China because, unlike in most European countries and the US, the plaintiff has the burden of proof in proving infringements.

Foreign patentees should have well-planned patent enforcement strategies and be prepared for evidence collection when encountering lawsuits in China.

The webinar will focus on the differences between the Chinese and US approaches to infringement litigation in the following areas:

  • The types of evidence required;

  • The factual evidence needed; and

  • Evidence regarding the claim amount.

Join Purplevine IP’s experts as they compare evidence collection for patent litigation in China with the approach in the US.

Register here to join Purplevine IP’s webinar on November 9 2022.

more from across site and SHARED ros bottom lb

More from across our site

Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Gift this article